BRIEF-GSK CEO says R&D costs coming down, trend to continue in 2014

Wed Oct 23, 2013 8:07am EDT

Oct 23 (Reuters) - GlaxoSmithKline Plc : * CEO says research and development costs coming down as expensive studies come

to end * CEO says controlled research and development cost trend likely to continue in

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.